Vicore Pharma Holding AB (VCRE)
$8.95-3.03%Close
SELL
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2.5B
- Beta
- 0.15
- P/E (TTM)
- -9.48
- Short % float
- 0.00%
- Days to cover
- 1.0
- SI change
- -57.0%
- 1W
- +2.40%
- 1M
- -19.80%
- vs SPY 1W
- +2.54%
- vs SPY 1M
- -22.31%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 11
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-28.9%
REV YoY-
ROE-48.2%
EPS YoY-
ROA-284.1%
GROSS100
OP-21455
NET-20490
[VALUATION]
P/E TTM-9.48
P/E FWD-
SECTOR PE20.34
INDUSTRY PE13.84
P/B283.47
P/FCF-
EV/EBITDA-100.67
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO12.68
ND/EBITDA-
BETA0.15
Company news
FAQ
- What is LOPJLB’s current signal on VCRE?
- LOPJLB’s latest quantitative signal on Vicore Pharma Holding AB (VCRE) is SELL. Signals are updated daily.
- What market regime is VCRE in?
- LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
- What does Vicore Pharma Holding AB (VCRE) do?
- Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.